|
1
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maucort-Boulch D, de Martel C, Franceschi
S and Plummer M: Fraction and incidence of liver cancer
attributable to hepatitis B and C viruses worldwide. Int J Cancer.
142:2471–2477. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singal AG, Pillai A and Tiro J: Early
detection, curative treatment, and survival rates for
hepatocellular carcinoma surveillance in patients with cirrhosis: A
meta-analysis. PLoS Med. 11:e10016242014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Julian L and Olson MF: Rho-associated
coiled-coil containing kinases (ROCK): Structure, regulation, and
functions. Small GTPases. 5:e298462014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schofield AV and Bernard O: Rho-associated
coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem
Mol Biol. 48:301–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang D, Du X, Yuan R, Chen L, Liu T, Wen
C, Huang M, Li M, Hao L and Shao J: Rock2 promotes the invasion and
metastasis of hepatocellular carcinoma by modifying MMP2
ubiquitination and degradation. Biochem Biophys Res Commun.
453:49–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peng F, Jiang J, Yu Y, Tian R, Guo X, Li
X, Shen M, Xu M, Zhu F, Shi C, et al: Direct targeting of
SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma
tumourigenesis and metastasis. Br J Cancer. 109:3092–3104. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang W, Zhou X and Wei M: MicroRNA-144
suppresses osteosarcoma growth and metastasis by targeting ROCK1
and ROCK2. Oncotarget. 6:10297–10308. 2015.PubMed/NCBI
|
|
12
|
Yang X, Zhao YU, Sun K, Li Y, Zhou J, Wang
J, Sun H, Wang CC, Kwong J, Wang H, et al: LncRNA HAND2-AS1
inactivates neuromedin U (NMU) and inhibits tumor invasion and
metastasis in endometrioid endometrial carcinoma. Cancer Rec.
3448:2017.f.
|
|
13
|
Kang Y, Zhu X, Xu Y, Tang Q, Huang Z, Zhao
Z, Lu J, Song G, Xu H, Deng C and Wang J: Energy stress-induced
lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and
inhibits osteosarcoma progression. Am J Cancer Res. 8:526–537.
2018.PubMed/NCBI
|
|
14
|
Zhou J, Lin J, Zhang H, Zhu F and Xie R:
LncRNA HAND2-AS1 sponging miR-1275 suppresses colorectal cancer
progression by upregulating KLF14. Biochem Biophys Res Commun.
503:1848–1853. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang X, Wang CC, Lee WYW, Trovik J, Chung
TKH and Kwong J: Long non-coding RNA HAND2-AS1 inhibits invasion
and metastasis in endometrioid endometrial carcinoma through
inactivating neuromedin U. Cancer Lett. 413:23–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM,
Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu
J, et al: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei L, Surma M, Shi S, Lambert-Cheatham N
and Shi J: Novel insights into the roles of Rho kinase in cancer.
Arch Immunol Ther Exp (Warsz). 64:259–278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li M, Zhou W, Yuan R, Chen L, Liu T, Huang
D, Hao L, Xie Y and Shao J: ROCK2 promotes HCC proliferation by
CEBPD inhibition through phospho-GSK3β/β-catenin signaling. FEBS
Lett. 589:1018–1025. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Q, Li X, Li X, Li X and Chen Z:
LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by
targeting miR-484 in human lung cancer cells. J Cell Biochem.
119:4447–4457. 2018. View Article : Google Scholar : PubMed/NCBI
|
